# Differences in Atorvastatin Metabolite Ratios as a Diagnostic Tool in Detecting Atorvastatin Induced Myotoxicity

> **NCT00199745** · PHASE4 · COMPLETED · sponsor: **Oslo University Hospital** · enrollment: 53 (estimated)

## Conditions studied

- Muscular Diseases

## Interventions

- **DRUG:** atorvastatin

## Key facts

- **NCT ID:** NCT00199745
- **Lead sponsor:** Oslo University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-10
- **Primary completion:** 2008-12
- **Final completion:** 2008-12
- **Target enrollment:** 53 (ESTIMATED)
- **Last updated:** 2012-05-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00199745

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00199745, "Differences in Atorvastatin Metabolite Ratios as a Diagnostic Tool in Detecting Atorvastatin Induced Myotoxicity". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00199745. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*